2025-12-25 - Analysis Report
Here's a breakdown of Northrop Grumman (NOC) based on the provided data:

**Company Overview:** Northrop Grumman Corp is a global aerospace and defense technology company.

**1. Return Rate Comparison:**

*   **NOC Cumulative Return:** 47.50%
*   **VOO (S&P 500) Cumulative Return:** 100.88%
*   **Divergence:** -53.38% (NOC underperformed VOO)
*   **Relative Divergence:** 5.2 (This indicates NOC's current performance relative to VOO is near the lower end of its historical divergence range).

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha   | Beta | Cap(B) |
|------------|--------|-------|---------|------|--------|
| 2015-2017  | 46.0%  | 65.6% | 17.0%   | 0.0  | 45.0   |
| 2016-2018  | -2.0%  | 74.3% | -17.0%  | 0.0  | 35.9   |
| 2017-2019  | 17.0%  | 79.2% | -5.0%   | 0.9  | 50.5   |
| 2018-2020  | -28.0% | 79.9% | -52.0%  | 0.8  | 44.7   |
| 2019-2021  | 43.0%  | 79.9% | -4.0%   | 0.8  | 56.8   |
| 2020-2022  | 18.0%  | 79.9% | 19.0%   | 0.3  | 80.0   |
| 2021-2023  | 24.0%  | 82.7% | 23.0%   | 0.2  | 68.7   |
| 2022-2024  | -15.0% | 82.7% | -36.0%  | 0.2  | 68.8   |
| 2023-2025  | -3.0%  | 82.1% | -68.0%  | 0.1  | 83.4   |

*   **CAGR (Compound Annual Growth Rate):** Fluctuates significantly, indicating periods of strong growth and contraction. The most recent period (2023-2025) shows a slight decline.
*   **MDD (Maximum Drawdown):** Consistently high, suggesting substantial potential losses during downturns.
*   **Alpha:**  Variable, sometimes outperforming the benchmark (positive alpha) and other times underperforming (negative alpha). Recent years show a significant negative alpha, indicating underperformance.
*   **Beta:** Generally low, indicating NOC has historically been less volatile than the overall market. Beta has decreased in recent years, approaching zero.
*   **Cap(B):** Market capitalization has increased over time, reaching a high of $83.4 billion in the latest period.

**2. Recent Stock Price Fluctuations:**

*   **Current Price:** $568.46
*   **Last Market Data:** Price: $582.35, Previous Close: $580.06, Change: $0.39
*   **5-day SMA:** $567.34
*   **20-day SMA:** $560.77
*   **60-day SMA:** $581.32

*   **Analysis:** The current price is slightly above the 5-day and 20-day SMAs, but below the 60-day SMA. This could suggest a short-term upward trend, but a longer-term downward trend might be developing.

**3. Indicators Analysis:**

*   **MRI (Market Risk Indicator):** 0.8 (Medium Investment Recommended)
*   **RSI (Relative Strength Index):** 65.35 (Approaching overbought territory)
*   **PPO (Percentage Price Oscillator):** 0.39 (Indicates a potential upward trend, but relatively weak)
*   **Hybrid Signal:** Buy 100% of cash (4 shares - Very Safe) - The high safety rating stems from the market risk indicator, but the RSI is approaching overbought levels and a PPO of 0.39% indicates the positive trends are very weak.
*   **Recent Divergence Change:** -0.5 (Short-term decline)
*   **Expected Return:** -151.2% (Significantly negative, suggesting underperformance compared to the S&P 500)

**4. Recent News & Significant Events:**

*   **Positive:** Several articles highlight analyst optimism with a potential 19% upside (Yahoo Finance, Insider Monkey). Northrop Grumman also secured a $100M missile weapon system contract (Finviz).
*   **Neutral/Negative:** Voya Investment Management LLC sold shares of NOC (MarketBeat). There is an article taking stock of valuation after a strong YTD price run (Sahm).
*   **Overall:** The news is mixed, with positive analyst sentiment and contract wins contrasted by share sales and valuation considerations.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean: 2.04)
*   **Target Price:** Average: $662.68, High: $770.00, Low: $533.00
*   **Analysis:** The analyst consensus is "Buy" with a significant upside potential based on the average target price. However, there are wide ranges of target prices which means there are difference in opinions.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-10-21 | 7.69 | 10.42 B$ |
| 2025-07-22 | 8.17 | 10.35 B$ |
| 2025-04-22 | 3.33 | 9.47 B$  |
| 2024-10-24 | 7.02 | 10.00 B$ |
| 2025-10-21 | 7.02 | 10.00 B$ |

*   **Trend:** Revenue has generally been increasing, but EPS has fluctuated significantly. The EPS for 2025-04-22 was notably lower.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30 | $10.42B    | 21.37%        |
| 2025-06-30 | $10.35B    | 21.35%        |
| 2025-03-31 | $9.47B     | 16.69%        |
| 2024-12-31 | $10.69B    | 18.08%        |
| 2024-09-30 | $10.00B    | 21.07%        |

*   **Trend:** Revenue has been relatively stable. Profit margin has shown some fluctuations, with the most recent quarters being relatively high.

**Capital and Profitability:**

| Quarter      | Equity      | ROE     |
|--------------|-------------|---------|
| 2025-09-30 | $15.99B    | 6.88%   |
| 2025-06-30 | $15.47B    | 7.59%   |
| 2025-03-31 | $14.98B    | 3.21%   |
| 2024-12-31 | $15.29B    | 8.27%   |
| 2024-09-30 | $14.75B    | 6.96%   |

*   **Trend:** Equity has been trending upward. ROE (Return on Equity) has fluctuated, with a significant drop in 2025-03-31.

**7. Comprehensive Analysis:**

Northrop Grumman (NOC) presents a mixed picture.

*   **Underperformance:** NOC has significantly underperformed the S&P 500 (VOO) over the analyzed period. This is reflected in the negative divergence and the significantly negative expected return.
*   **Mixed Signals:** While analyst consensus is a "Buy" with a target price significantly higher than the current price, several technical indicators like RSI, PPO and recent divergence change are not strong.
*   **Financials:** Revenue and profit margins are relatively stable, but ROE has fluctuated.
*   **News:** Recent news is mixed, with positive analyst sentiment and contract wins offset by share sales.
*   **Risk:** The high MDD values in the Alpha, Beta analysis indicate significant potential downside risk. The low Beta values suggest that any potential volatility is independent of the S\&P500.
*   **Recommendation:** Based on the data, a cautious approach is warranted. While analyst opinions and recent contract wins are positive, the underperformance relative to the S&P 500, the mixed technical indicators, and the high MDD suggest careful consideration of risk factors. If considering investment, weigh the potential upside against the potential for significant losses. Further research into the reasons for the recent underperformance and the fluctuations in EPS and ROE would be beneficial.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.